SUCCESSFUL TREATMENT OF A PROLACTIN-PRODUCING PITUITARY MACROADENOMA WITH INTRAVAGINAL BROMOCRIPTINE MESYLATE: A NOVEL APPROACH TO INTOLERANCE OF ORAL THERAPY